Detection of SARS-CoV-2 Antibodies in Oral Fluid Obtained Using a Rapid Collection Device
- 21 January 2021
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 59 (2)
Abstract
Current commercially available methods for reliably detecting antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remain expensive and inaccessible due to the need for whole-blood collection by highly trained phlebotomists using personal protective equipment (PPE). We have evaluated an antibody detection approach using the OraSure Technologies oral antibody collection device (OACD) and their proprietary SARS-CoV-2 total antibody detection enzyme-linked immunosorbent assay (ELISA).Keywords
All Related Versions
This publication has 8 references indexed in Scilit:
- ELISA detection of SARS-CoV-2 antibodies in salivaScientific Reports, 2020
- Quantification of antibody avidities and accurate detection of SARS-CoV-2 antibodies in serum and saliva on plasmonic substratesNature Biomedical Engineering, 2020
- Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patientsScience Immunology, 2020
- Salivary anti-SARS-CoV-2 IgA as an accessible biomarker of mucosal immunity against COVID-19medRxiv, 2020
- COVID-19 serology at population scale: SARS-CoV-2-specific antibody responses in salivamedRxiv, 2020
- Antibody responses to SARS-CoV-2 in patients with COVID-19Nature Medicine, 2020
- Technical Guidelines for COVID-19 Laboratory TestingChina CDC Weekly, 2020
- The mucosal immune system: from fundamental concepts to vaccine developmentVaccine, 1992